FDA Inspection 920664 — Eurofins Biopharma Product Testing Sweden AB

Eurofins Biopharma Product Testing Sweden AB — FEI 3008759559

The FDA completed an inspection of Eurofins Biopharma Product Testing Sweden AB on March 9, 2015 in Uppsala. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 9, 2015
Fiscal Year
2015
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Uppsala (Sweden)